Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on NSPH, STZ, and UTHR Issued by the Bedford Report

STZ, UTHR
Free Research Reports on NSPH, STZ, and UTHR Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986352&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 02/15/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Nanosphere, Inc. (NASDAQ: NSPH) shares declined over 30 percent on more than twenty times the average daily volume Thursday. Despite reporting record revenues of $1.6 million in the fourth quarter, shares of Nanosphere declined after lowering its first-quarter placement targets of 45 to 55 placements from its previous estimate of 80 to 100 placements.

Find out more about Nanosphere including full access to the free equity report at: www.BedfordReport.com/NSPH

Constellation Brands, Inc. (NYSE: STZ) shares soared nearly 40 percent on over 50 million shares traded Thursday. The company and Anheuser-Busch InBev NV have recently announced a revised agreement for the complete divestiture of Grupo Modelo's U.S. business.

Find out more about Constellation Brands including full access to the free equity report at: www.BedfordReport.com/STZ

United Therapeutics Corporation (NASDAQ: UTHR) shares surged 4.25 percent on nearly four times the average daily volume Thursday. The company reported the FDA has acknowledged the resubmission of the new drug application for treprostinil diolamine.

Find out more about United Therapeutics including full access to the free equity report at: www.BedfordReport.com/UTHR

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today